Abstract:Introduction Hereditary antithrombin (AT) deficiency is a rare autosomal dominant disorder with significant clinical heterogeneity. In the study, we identified a patient with AT deficiency caused by compound heterozygous mutations in the SERPINC1 gene. Methods A total of 9 individuals from three generations were investigated. The mutations were identified by direct sequencing of SERPINC1 . Multiple in silico tools were programmed to predict the conservation of mutations and the effect on the AT structure. The coagulation state was evaluated by the thrombin generation assay. Recombinant AT was overexpressed in HEK293T cells; the mRNA level was determined using RT-qPCR. Western blotting, ELISA, and immunocytofluorescence were applied to characterize the recombinant AT protein. Results The proband was a 26-year-old male who experienced recurrent venous thrombosis. He presented the type I deficiency with 33% AT activity and a synchronized decrease in AT antigen. Genetic screening revealed that he carried a heterozygous c.318_319insT (p.Asn107*) in exon 2 and a heterozygous c.922G>T (p.Gly308Cys) in exon 5, both of which were completely conserved in homologous species and resulted in enhanced thrombin generation capability. Hydrophobicity analysis suggested that the p.Gly308Cys mutation may interfere with the hydrophobic state of residues 307-313. In vitro expression studies indicated that the levels of the recombinant protein AT-G308C decreased to 46.98% ± 2.94% and 41.35% ± 1.48% in transfected cell lysates and media, respectively. After treatment with a proteasome inhibitor (MG132), the quantity of AT-G308C protein in the cytoplasm was replenished to a level comparable to that of the wild type. The mRNA level of AT-N107* was significantly reduced and the recombinant protein AT-N107* was not detected in either the lysate or the culture media. Conclusion These two mutations were responsible for the AT defects and clinical phenotypes of the proband. The p.Gly308Cys mutation could lead to proteasome-dependent degradation of the AT protein in the cytoplasm by altering local residue hydrophobicity. The c.318_319insT could eliminate aberrant transcripts by triggering nonsense-mediated mRNA degradation. Both mutations resulted in type I AT deficiency.

SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes

Insights into the Pathogenesis of Hereditary Angioedema Using Genetic Sequencing and Recombinant Protein Expression Analyses

Novel genetic modifiers of the clinical phenotype in patients with hereditary angioedema due to C1 inhibitor deficiency

Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort

Transmission patterns of C1-INH deficiency hereditary angioedema favors a wild-type male offspring: Our experience at Chandigarh, India

Uncovering a novel SERPING1 pathogenic variant: insights into the aggregation of C1-INH in hereditary angioedema

A novel mutation in exon 8 of C1 inhibitor (C1INH) gene leads to abolish its physiological stop codon in a large Chinese family with hereditary angioedema type I.

Clinical and functional characterization of rare compound heterozygous mutations in the SERPINC1 gene causing severe thrombophilia

Heterozygous SERPINA1 Defects and Their Impact on Clinical Manifestations of Patients with Predominantly Antibody Deficiencies

SERPING1 polymorphisms in polypoidal choroidal vasculopathy.

A novel SERPINC1 c.119G>A (p.Cys40Tyr) mutation with variable clinical expression in an Indian family

I440V mutation in C1 esterase inhibitor gene in a patient with hereditary angioedema and its influence to the structure of C1 esterase inhibitor

Recurrent Mutations in Aserpinc1hotspot Associate with Venous Thrombosis Without Apparent Antithrombin Deficiency

Rare SERPINA1 variants leading to severe Alpha-1 Antitrypsin Deficiency

Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency

Clinical Manifestations and Gene Analysis of 18 Cases of Hereditary Protein S Deficiency

A Predominant Mutation in Regulatory Region of Serpinc1 Gene and Venous Thrombosis

C1 inhibitor deficiency enhances contact pathway-mediated activation of coagulation and venous thrombosis

Complicated Hereditary Spastic Paraplegia Caused by SERAC1 Variants in a Chinese Family

Hereditary angioedema with normal C1-Inhibitor: Clinical and genetic characterization of 15 Portuguese unrelated families.

SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency